Skip to content

Instrument Precision Study for Validation of Philips Dx

Instrument Precision Study for Validation of Philips Dx

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02699970
Enrollment
399
Registered
2016-03-07
Start date
2016-02-29
Completion date
2016-10-31
Last updated
2019-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pathology

Brief summary

The objective of this study is to evaluate precision of the Philips Dx system.

Detailed description

Slides were selected that contained clinically relevant histopathologic features that are generally encountered on surgical pathology slides. Twenty-one features, each selected from three different organs, were to be included to ensure that multiple tissue types were investigated. The study feature(s) as selected on each slide was defined as the selected feature. In total 420 selected features were acquired and the slides holding these features composed the slide set. The slideset consisted of 399 slides from 399 different participants. 1. Intra-system study. The full slide set was then divided over three subsets. Each subset was then scanned three times on one systems, with each subset being scanned on a different scanner. This means that each feature was scanned three times. Each of three pathologists read all three scans of the entire slide set. Intra-system precision was thereby determined. 2. Inter-system study. The full slide set was then scanned three times, each time on a different system, meaning that each feature was scanned three times. Each of three pathologists (different pathologists the ones used in the intra-system study) read all three scans of the entire slide set. Inter-system precision was thereby determined.

Interventions

None listed

Sponsors

Philips Digital & Computational Pathology
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Left-over specimens from subjects who already received their diagnosis and have received their treatment in accordance with the standard of care * H&E glass coverslipped slides with human tissue obtained via surgical pathology * Selected slides fulfill the quality checks according to the Instructions for Use (lfU) * Selected slides must be between 1-5 years since accessioning * Selected slides and FOVs must contain a study feature that is: In it's natural environment (on slide and FOV); Readily observable (on slide and FOV); Not equivocal (on slide and FOV).

Exclusion criteria

* Selected slides contain indelible markings * Selected slides contain damaged tissue * More than one slide was selected for a patient (only one slide may be enrolled per patient).

Design outcomes

Primary

MeasureTime frameDescription
Agreement Rate2 monthsThe agreement rate between reads calculated over all selected features and pathologists. Readings were considered in agreement when the selected feature was indicated as 'present' or 'absent' in both readings.

Countries

United States

Participant flow

Recruitment details

The study started enrollment in February 2016 and enrollment was completed in April 2016. The full set of 420 features were used for the intra-system study as well as for the inter-system sub-study.

Pre-assignment details

Features were evenly distributed over three magnifications (10x, 20x or 40x). 21 different feature types were included. Each feature type was divided over three organs.

Participants by arm

ArmCount
Precision
Intra-system: At one study site the slides with selected features were evenly distributed over three different systems. Each slide was scanned three times on the same system. All scans were read by all three pathologists. Inter-system: At one study site the full set of slides with selected features was scanned once on three different scanners. All three pathologists read all scans.
399
Precision
Intra-system: At one study site the slides with selected features were evenly distributed over three different systems. Each slide was scanned three times on the same system. All scans were read by all three pathologists. Inter-system: At one study site the full set of slides with selected features was scanned once on three different scanners. All three pathologists read all scans.
420
Total819

Baseline characteristics

CharacteristicPrecision
Region of Enrollment
United States
420 Study features

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 399
other
Total, other adverse events
0 / 399
serious
Total, serious adverse events
0 / 399

Outcome results

Primary

Agreement Rate

The agreement rate between reads calculated over all selected features and pathologists. Readings were considered in agreement when the selected feature was indicated as 'present' or 'absent' in both readings.

Time frame: 2 months

Population: For the intra-system sub-study 2 cases were not analyzed for possible reading bias due to an error in the EDC system.~For the inter-system sub-study 3 cases were not analyzed for different reasons such as possible reading bias due to an error in the EDC system (2) and a short washout period (1).

ArmMeasureValue (MEAN)
Intra-system Sub-studyAgreement Rate92.0 percentage of agreement
Inter-system Sub-studyAgreement Rate93.8 percentage of agreement

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026